Drug Trial Radar · NCT03357614
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
Last checked: Nov 19, 2026Latest source record: Dec 29, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,395
Actual
Start
Sep 18, 2018
Primary completion
Dec 14, 2019
Study completion Dec 14, 2019
Sponsor
- Lead sponsor
- Iterum Therapeutics, International LimitedIndustry
- Sponsor type
- Industry
- First posted
- Nov 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, phase 3, randomized, multicenter, double-blind, double-dummy study to compare the efficacy and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for the treatment of complicated urinary tract infections (cUTI) in adults.
Conditions
- Complicated Urinary Tract Infections
Interventions
SulopenemDrug
Antibiotic therapy for complicated UTI
Sulopenem-Etzadroxil/ProbenecidDrug
Antibiotic therapy for complicated UTI
ErtapenemDrug
Antibiotic therapy for complicated UTI
CiprofloxacinDrug
Antibiotic therapy for complicated UTI
Amoxicillin-clavulanateDrug
Antibiotic therapy for complicated UTI
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Overall SuccessTime frame: Day 21 +/- 1 day
Locations
32 sites in 5 countries. Site status is shown where the registry gives one.
Medical Facility
Bellflower, California
Medical Facility
Chula Vista, California
Medical Facility
La Mesa, California
Medical Facility
La Palma, California
Medical Facility
Torrance, California
Medical Facility
Miami Lakes, Florida
Medical Facility
Columbus, Georgia
Medical Facility
Idaho Falls, Idaho
Medical Facility
Boston, Massachusetts
Medical Facility
Royal Oak, Michigan
Medical Facility
Butte, Montana
Medical Facility
Columbus, Ohio
Medical Facility
Columbus, Ohio
Medical Facility
Dallas, Texas
Medical Facility
Houston, Texas
Medical Facility
Kohtla-Järve, Estonia
Medical Facility
Tallinn, Estonia
Medical Facility
Võru, Estonia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Baja, Hungary
Medical Facility
Budapest, Hungary
Medical Facility
Nagykanizsa, Hungary
Medical Facility
Nyíregyháza, Hungary
Medical Facility
Szentes, Hungary
Medical Facility
Tatabánya, Hungary
Medical Facility
Daugavpils, Latvia
Medical Facility
Liepāja, Latvia
Medical Facility
Riga, Latvia
Medical Facility
Riga, Latvia
Medical Facility
Valmiera, Latvia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.